Develops drugs for epilepsy and depression.
Jun 2026Revenue $0.00/yrExpenses $442M/yr
No trendCash runway ≈ 2.7 years from Jun 2026
Figures by year
When will Xenon Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $0.00 and expenses $442M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $7.50M | $381M | −$373M |
| Dec 2024 | $0.00 | $279M | −$279M |
| Dec 2023 | $0.00 | $214M | −$214M |
| Dec 2022 | $9.43M | $139M | −$129M |
| Dec 2021 | $18.4M | $97.4M | −$79.0M |
| Dec 2020 | $32.2M | $63.5M | −$31.3M |
| Dec 2019 | $6.83M | $49.6M | −$42.8M |
| Dec 2017 | $311K | $32.9M | −$32.6M |
| Dec 2016 | $1.80M | $26.6M | −$24.8M |
| Dec 2015 | $15.6M | $24.9M | −$9.36M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.